AU5827590A - Htlv-1 env gene products expressed in (e. coli) - Google Patents

Htlv-1 env gene products expressed in (e. coli)

Info

Publication number
AU5827590A
AU5827590A AU58275/90A AU5827590A AU5827590A AU 5827590 A AU5827590 A AU 5827590A AU 58275/90 A AU58275/90 A AU 58275/90A AU 5827590 A AU5827590 A AU 5827590A AU 5827590 A AU5827590 A AU 5827590A
Authority
AU
Australia
Prior art keywords
htlv
coli
gene products
env gene
products expressed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58275/90A
Inventor
Mark D. Chamberlain
David E. Tribe
Radonna J. Tritch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Publication of AU5827590A publication Critical patent/AU5827590A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/14011Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU58275/90A 1989-06-01 1990-05-23 Htlv-1 env gene products expressed in (e. coli) Abandoned AU5827590A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35961489A 1989-06-01 1989-06-01
US359614 1989-06-01

Publications (1)

Publication Number Publication Date
AU5827590A true AU5827590A (en) 1991-01-07

Family

ID=23414595

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58275/90A Abandoned AU5827590A (en) 1989-06-01 1990-05-23 Htlv-1 env gene products expressed in (e. coli)

Country Status (3)

Country Link
AU (1) AU5827590A (en)
CA (1) CA2017936A1 (en)
WO (1) WO1990015075A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU690540B2 (en) * 1993-02-05 1998-04-30 Genelabs Technologies, Inc. HTLV-I and HTLV-II gp21 derived peptides for use in diagnostics

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2072346T3 (en) * 1989-10-23 1995-07-16 Hoffmann La Roche SYNTHETIC PEPTIDES ON THE HTLV-I COVER.
AU7258491A (en) * 1990-02-09 1991-09-03 E.I. Du Pont De Nemours And Company Htlv envelope antigenic segment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724258A (en) * 1984-02-03 1988-02-09 Juridical Foundation, Japanese Foundation For Cancer Research Adult T cell leukemia virus antigen polypeptide
JP2564268B2 (en) * 1985-08-28 1996-12-18 協和醗酵工業株式会社 Fusion antigen polypeptide
EP0246101A3 (en) * 1986-05-14 1989-06-07 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Protein having htlv-1 antigenic activity and preparation thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU690540B2 (en) * 1993-02-05 1998-04-30 Genelabs Technologies, Inc. HTLV-I and HTLV-II gp21 derived peptides for use in diagnostics

Also Published As

Publication number Publication date
WO1990015075A1 (en) 1990-12-13
CA2017936A1 (en) 1990-12-01

Similar Documents

Publication Publication Date Title
AU634551B2 (en) Imidazolyl-alkenoic acids
AU4802896A (en) Phosphonomonoester nucleic acids, process for their preparation, and their use
AU6784490A (en) Pharmaceuticals
AU608648B2 (en) Non-alcoholic beer
AU4691789A (en) N-aryl-azetidinones, their preparation process and their use as elastase inhibitors
AU1480988A (en) Water-soluble cationic polymer
AU2076692A (en) Copolyesters, copolyamides and copolyester-amides
AU4648589A (en) Multi-fuseable shaft
AU2589688A (en) Diarylstyrylquinoline diacids
AU5189590A (en) Vertically aligned batch baker
AU5342290A (en) Cd8-based pharmaceuticals
AU6245790A (en) Regulatory dna sequence
AU5542890A (en) Wear-resistant laminated articles
AU5606790A (en) Shaped articles
AU612401B2 (en) Beer
AU5100690A (en) Motorless carbonator
AU632855B2 (en) Novel alpha-glucosidase inhbitors
AU6397090A (en) Benzoxazinyl-pyrazoles, and their production and use
AU5827590A (en) Htlv-1 env gene products expressed in (e. coli)
AU5708690A (en) Lift shaft construction
AU637650B2 (en) 3-fluorosulfonyloxyceph-3-em displacement process
AU630181B2 (en) Enzyme luminescence assay
AU1134197A (en) The modular, adaptable puzzle
AU622787B2 (en) Product stabilizer
AU1516888A (en) Des-19-leucine, 20-glutamine, 21-threonine-calcitronin